Medicago Growth, Revenue, Number of Employees and Funding

Overview

Location:
Quebec City, QC Canada
Total Funding:N/A
Industry:Biotech
Founded:1999
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Medicago's estimated revenue is currently $50.7M per year.
  • Medicago's estimated revenue per employee is $144814

Employee Data

  • Medicago has 350 Employees.
  • Medicago grew their employee count by 17% last year.
  • Medicago currently has N/A job openings.

Executive Contacts

NameTitle
Wally BrissonDirector, Operations Planning, Operational Excellence, and Business Excellence
Daniel HoudeSenior Director Clinical Studies
Jim ZemonekSr. Director, Head of IT
Charlie HilliardDirector of Engineering
Chuck HowrenDirector, Enterprise Information Management
Pat SchimkeVice President of Analytical Development and Quality Control
Lorrie DeyelleVice President Human Resources
Mélanie BérubéDirector-Preclinical Studies
Jean CharbonneauVice-président Qualité
Geneviève MercierDirector

What Is Medicago?

Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based manufacturing and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges. The story of Medicago is rooted in a long track record of innovation and perseverance. Even our company name the Latin word for alfalfa, which was the first plant we worked with embodies our culture of adaptation. We're proud of our humble beginnings as much as we are of our current growth and global reach. We understand better than most that the path to success in not a straight line. As a pioneer of plant-based transient expression and manufacturing, Medicago has always sought a more effective way to improve human health. With nearly 20 years of experience and wisdom behind us, we are ready to disrupt the traditional approach to vaccines and therapeutics.

keywords:Biotechnology,E-Commerce,Healthcare,Pharmaceuticals

350

Number of Employees

$50.7M

Revenue (est)

N/A

Current Jobs

17%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
NEOMED-LABS
$7.3M506%N/A
Jefo
$22M15210%N/A
GC Biotherapeut...
$11.6M8019%N/A
Génome Québec
$10.4M726%N/A
Medicago
$50.7M35017%N/A
InnuScience
$9.9M688%N/A

Medicago News

3-Sep-19 - Plant Gene Discovery May Help Reduce Fertilizer Pollution in ...

Boyce Thompson Institute researchers used Brachypodium distachyon (left) and Medicago truncatula (right) to discover the roles of two genes ...

12-Sep-19 - Rotavirus Infections Drug Market will Generate Massive ...

Rotavirus Infections Drug Market will Generate Massive Revenue in Future- Key Players-Curevac AG, Medicago , Nanotherapeutics.

2-Sep-19 - Plant gene breakthrough can help battle fertilizer pollution in ...

... Harrison and colleAuge Lena Müller studied genes that encode short proteins called CLE peptides in two plants — Medicago truncatula and ...